These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 10791873

  • 1. Anti-human immunodeficiency virus activity of novel aminoglycoside-arginine conjugates at early stages of infection.
    Cabrera C, Gutiérrez A, Blanco J, Barretina J, Litovchick A, Lapidot A, Evdokimov AG, Clotet B, Esté JA.
    AIDS Res Hum Retroviruses; 2000 May 01; 16(7):627-34. PubMed ID: 10791873
    [Abstract] [Full Text] [Related]

  • 2. Aminoglycoside-arginine conjugates that bind TAR RNA: synthesis, characterization, and antiviral activity.
    Litovchick A, Evdokimov AG, Lapidot A.
    Biochemistry; 2000 Mar 21; 39(11):2838-52. PubMed ID: 10715103
    [Abstract] [Full Text] [Related]

  • 3. Structure-activity relationship of neomycin, paromomycin, and neamine-arginine conjugates, targeting HIV-1 gp120-CXCR4 binding step.
    Borkow G, Vijayabaskar V, Lara HH, Kalinkovich A, Lapidot A.
    Antiviral Res; 2003 Nov 21; 60(3):181-92. PubMed ID: 14638394
    [Abstract] [Full Text] [Related]

  • 4. Structure-function relationship of novel X4 HIV-1 entry inhibitors - L- and D-arginine peptide-aminoglycoside conjugates.
    Hegde R, Borkow G, Berchanski A, Lapidot A.
    FEBS J; 2007 Dec 21; 274(24):6523-36. PubMed ID: 18028446
    [Abstract] [Full Text] [Related]

  • 5. The antiviral activity of the CXCR4 antagonist AMD3100 is independent of the cytokine-induced CXCR4/HIV coreceptor expression level.
    Princen K, Hatse S, Vermeire K, Bridger GJ, Skerlj RT, De Clercq E, Schols D.
    AIDS Res Hum Retroviruses; 2003 Dec 21; 19(12):1135-9. PubMed ID: 14709250
    [Abstract] [Full Text] [Related]

  • 6. Mutation of Asp(171) and Asp(262) of the chemokine receptor CXCR4 impairs its coreceptor function for human immunodeficiency virus-1 entry and abrogates the antagonistic activity of AMD3100.
    Hatse S, Princen K, Gerlach LO, Bridger G, Henson G, De Clercq E, Schwartz TW, Schols D.
    Mol Pharmacol; 2001 Jul 21; 60(1):164-73. PubMed ID: 11408611
    [Abstract] [Full Text] [Related]

  • 7. Anti-HIV activity of a novel aminoglycoside-arginine conjugate.
    Cabrera C, Gutiérrez A, Barretina J, Blanco J, Litovchick A, Lapidot A, Clotet B, Esté JA.
    Antiviral Res; 2002 Jan 21; 53(1):1-8. PubMed ID: 11684311
    [Abstract] [Full Text] [Related]

  • 8. Resistance of the human immunodeficiency virus to the inhibitory action of negatively charged albumins on virus binding to CD4.
    Cabrera C, Witvrouw M, Gutiérrez A, Clotet B, Kuipers ME, Swart PJ, Meijer DK, Desmyter J, De Clercq E, Esté JA.
    AIDS Res Hum Retroviruses; 1999 Nov 20; 15(17):1535-43. PubMed ID: 10580404
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-azamacrocycles that inhibit HIV-1 and HIV-2 replication by antagonism of the chemokine receptor CXCR4.
    Bridger GJ, Skerlj RT, Padmanabhan S, Martellucci SA, Henson GW, Struyf S, Witvrouw M, Schols D, De Clercq E.
    J Med Chem; 1999 Sep 23; 42(19):3971-81. PubMed ID: 10508445
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of human immunodeficiency virus replication by a dual CCR5/CXCR4 antagonist.
    Princen K, Hatse S, Vermeire K, Aquaro S, De Clercq E, Gerlach LO, Rosenkilde M, Schwartz TW, Skerlj R, Bridger G, Schols D.
    J Virol; 2004 Dec 23; 78(23):12996-3006. PubMed ID: 15542651
    [Abstract] [Full Text] [Related]

  • 11. NeoR6 inhibits HIV-1-CXCR4 interaction without affecting CXCL12 chemotaxis activity.
    Lapidot A, Peled A, Berchanski A, Pal B, Kollet O, Lapidot T, Borkow G.
    Biochim Biophys Acta; 2008 Jun 23; 1780(6):914-20. PubMed ID: 18410746
    [Abstract] [Full Text] [Related]

  • 12. Anti-HIV activity and resistance profile of the CXC chemokine receptor 4 antagonist POL3026.
    Moncunill G, Armand-Ugón M, Clotet-Codina I, Pauls E, Ballana E, Llano A, Romagnoli B, Vrijbloed JW, Gombert FO, Clotet B, De Marco S, Esté JA.
    Mol Pharmacol; 2008 Apr 23; 73(4):1264-73. PubMed ID: 18182480
    [Abstract] [Full Text] [Related]

  • 13. A peptide derived from bee venom-secreted phospholipase A2 inhibits replication of T-cell tropic HIV-1 strains via interaction with the CXCR4 chemokine receptor.
    Fenard D, Lambeau G, Maurin T, Lefebvre JC, Doglio A.
    Mol Pharmacol; 2001 Aug 23; 60(2):341-7. PubMed ID: 11455021
    [Abstract] [Full Text] [Related]

  • 14. The simian immunodeficiency virus mnd(GB-1) strain uses CXCR4, not CCR5, as coreceptor for entry in human cells.
    Schols D, De Clercq E.
    J Gen Virol; 1998 Sep 23; 79 ( Pt 9)():2203-5. PubMed ID: 9747729
    [Abstract] [Full Text] [Related]

  • 15. CD4-Chemokine receptor hybrids in human immunodeficiency virus type 1 infection.
    Klasse PJ, Rosenkilde MM, Signoret N, Pelchen-Matthews A, Schwartz TW, Marsh M.
    J Virol; 1999 Sep 23; 73(9):7453-66. PubMed ID: 10438835
    [Abstract] [Full Text] [Related]

  • 16. AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor.
    Donzella GA, Schols D, Lin SW, Esté JA, Nagashima KA, Maddon PJ, Allaway GP, Sakmar TP, Henson G, De Clercq E, Moore JP.
    Nat Med; 1998 Jan 23; 4(1):72-7. PubMed ID: 9427609
    [Abstract] [Full Text] [Related]

  • 17. T-cell-line-tropic human immunodeficiency virus type 1 that is made resistant to stromal cell-derived factor 1alpha contains mutations in the envelope gp120 but does not show a switch in coreceptor use.
    Schols D, Esté JA, Cabrera C, De Clercq E.
    J Virol; 1998 May 23; 72(5):4032-7. PubMed ID: 9557691
    [Abstract] [Full Text] [Related]

  • 18. Neomycin B-arginine conjugate, a novel HIV-1 Tat antagonist: synthesis and anti-HIV activities.
    Litovchick A, Lapidot A, Eisenstein M, Kalinkovich A, Borkow G.
    Biochemistry; 2001 Dec 25; 40(51):15612-23. PubMed ID: 11747436
    [Abstract] [Full Text] [Related]

  • 19. Discovery of novel small molecule orally bioavailable C-X-C chemokine receptor 4 antagonists that are potent inhibitors of T-tropic (X4) HIV-1 replication.
    Skerlj RT, Bridger GJ, Kaller A, McEachern EJ, Crawford JB, Zhou Y, Atsma B, Langille J, Nan S, Veale D, Wilson T, Harwig C, Hatse S, Princen K, De Clercq E, Schols D.
    J Med Chem; 2010 Apr 22; 53(8):3376-88. PubMed ID: 20297846
    [Abstract] [Full Text] [Related]

  • 20. HIV co-receptors as targets for antiviral therapy.
    Schols D.
    Curr Top Med Chem; 2004 Apr 22; 4(9):883-93. PubMed ID: 15134547
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.